$ACRX ACELRX PHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in ACELRX PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACELRX PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in ACELRX PHARMACEUTICALS INC for free.
CIK Number: 0001427925
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ACRX
Company Address: 351 GALVESTON DRIVE REDWOOD CITY 94063
Phone number: 650-216-3500
Former name: Surx, Inc.
Market Capitalization: $131.47M
Prev close: $3.00
Average Daily Volume: 226,447
Days Low: $2.90
Year Low: $2.40
Year High: $4.50
ACELRX PHARMACEUTICALS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2021 | ACRX | ACELRX PHARMACEUTI ... | Bozilenko Marina | Director | Option Exercise | A | 1.61 | 30,000 | 48,300 | 30,000 | |
Mar 31 2021 | ACRX | ACELRX PHARMACEUTI ... | Bozilenko Marina | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Palmer Pamela P | Chief Medical Offic ... | Option Exercise | A | 1.88 | 68,750 | 129,250 | 68,750 | |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Palmer Pamela P | Chief Medical Offic ... | Option Exercise | A | 1.88 | 137,500 | 258,500 | 137,500 | |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Palmer Pamela P | Chief Medical Offic ... | Grant | A | 0.00 | 68,750 | 0 | 666,621 | 597.9 K to 666.6 K (+11.50 %) |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 1.88 | 50,000 | 94,000 | 50,000 | |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Option Exercise | A | 1.88 | 100,000 | 188,000 | 100,000 | |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Grant | A | 0.00 | 50,000 | 0 | 204,757 | 154.8 K to 204.8 K (+32.31 %) |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Option Exercise | A | 1.88 | 68,750 | 129,250 | 68,750 | |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Option Exercise | A | 1.88 | 137,500 | 258,500 | 137,500 | |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Grant | A | 0.00 | 68,750 | 0 | 260,597 | 191.8 K to 260.6 K (+35.84 %) |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Option Exercise | A | 1.88 | 1,000,000 | 1,880,000 | 1,000,000 | |
Mar 05 2021 | ACRX | ACELRX PHARMACEUTI ... | Angotti Vincent J. | Chief Executive Off ... | Grant | A | 0.00 | 200,000 | 0 | 636,980 | 437 K to 637 K (+45.77 %) |
Feb 12 2021 | ACRX | ACELRX PHARMACEUTI ... | ASADORIAN RAFFI | Chief Financial Off ... | Payment of Exercise | F | 2.63 | 9,024 | 23,733 | 183,299 | 192.3 K to 183.3 K (-4.69 %) |
Feb 12 2021 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Payment of Exercise | F | 2.63 | 6,775 | 17,818 | 144,757 | 151.5 K to 144.8 K (-4.47 %) |